News
Rinri Therapeutics, a world leading spinout company from the University of Sheffield dedicated to transforming sensorineural ...
UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural ...
Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with bronchiectasis, which is a chronic and progressive lung condition that ...
Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function.
4d
Paulick Report on MSNHorse Owners: New Website Includes Science-Based Resources On Equine WellnessThe site was created by Boehringer Ingelheim after a survey identified knowledge gaps among owners on many health topics ...
TOKYO -- German drugmaker Boehringer Ingelheim plans to invest a total of 300 million euros ($346 million) in its plant in Japan from 2023 to 2028 as it moves to make the facility a production base ...
Boehringer Ingelheim launches innovative poultry vaccine in India, offering single-dose protection against major diseases, ...
What happens when data projects forget the people who use them? A Disconnect. Boehringer Ingelheim turned things around by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results